Year archive

Evolva Holding SA — 2023 filings

All 22 regulatory filings released by Evolva Holding SA (EVE) in 2023, sourced directly from the official regulator.

22 Filings

2023 Period

2023 filings (22)

Filing	Released	Lang
Evolva and Lallemand close the sale of Evolva AG to Danstar Ferment AG on 28 December 2023 Delisting Announcement	2023-12-28	English
Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting Delisting Announcement	2023-12-21	English
Evolva convenes extraordinary general meeting (EGM) for 21 December 2023 to approve the sale of Evolva AG to Lallemand Inc. AGM Information	2023-11-30	English
Evolva enters into an agreement to sell its operations to Lallemand, securing the best possible outcome for the company and its stakeholders M&A Activity	2023-11-21	English
Evolva and Breko broaden partnership by signing agreement for the exclusive distribution of Veri-teTM Resveratrol in Germany, Austria, Thailand and Vietnam M&A Activity	2023-11-14	English
Evolva and LEHVOSS sign agreement for distribution of Veri-teTM Resveratrol in over a dozen European countries M&A Activity	2023-09-28	English
Evolva and Nice & Green agree on improvements to financing agreement Capital/Financing Update	2023-09-13	English
Evolva receives approval for Veri-teTM Resveratrol in Thailand Regulatory Filings	2023-09-06	English
Evolva shareholders approve increase of the conditional capital and upper limit of capital band at extraordinary general meeting of 24 August 2023 AGM Information	2023-08-24	English
Evolva with good business momentum and significant progress in profitability in 1H 2023, despite major financing challenges Earnings Release H1 2023	2023-08-24	English
Evolva Holding SA: Evolva convenes extraordinary general meeting (EGM) for 24 August 2023 to secure financing until end of the year AGM Information	2023-07-28	English
Evolva receives approval for Veri-teTM Resveratrol in Taiwan Regulatory Filings	2023-07-25	English
Evolva Holding SA: Evolva signs agreement with Nice & Green to secure financing at least until the end of 2023, continues to pursue strategic alternatives Capital/Financing Update	2023-06-26	English
Evolva informs about renegotiation of financing arrangement, initiates review of strategic alternatives and revokes guidance Capital/Financing Update	2023-06-14	English
Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026 Regulatory Filings	2023-05-05	English
Evolva publishes timeline of the Reverse Stock Split Delisting Announcement	2023-04-24	English
Evolva shareholders approve all motions proposed by the Board at todays Annual General Meeting AGM Information	2023-04-18	English
Evolva goes Responsible Care at in-cosmetics 2023 Regulatory Filings	2023-03-28	English
Evolva publishes agenda for 2023 Annual General Meeting AGM Information	2023-03-24	English
Evolva delivers accelerated revenue growth of 57% in 2022 and substantially improved profitability profile Earnings Release FY 2022	2023-03-09	English
Evolva partners with Grace Breeding to replace chemical fertilizers with nature-based alternative Regulatory Filings	2023-03-06	English
Evolva delivers strong results with 57% revenue growth and increasing margins Earnings Release FY 2022	2023-01-11	English